Filing Details

Accession Number:
0001127602-24-012991
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-16 16:23:00
Reporting Period:
2024-04-15
Accepted Time:
2024-04-16 16:23:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA Biological Products, (No Disgnostic Substances) (2836) 813467528
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760669 Stephen Hoge C/O Moderna, Inc.
325 Binney Street
Cambridge MA 02142
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-04-15 15,000 $105.02 1,486,241 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,116 Indirect By Valhalla, LLC
Common Stock 151,933 Indirect By Trust
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2023.
  2. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.